Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
88.78
+2.48 (2.87%)
At close: Mar 9, 2026, 4:00 PM EDT
88.75
-0.03 (-0.03%)
After-hours: Mar 9, 2026, 4:54 PM EDT
Mirum Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 296.68 | 222.5 | 286.33 | 28 | 31.34 | Upgrade
|
| Short-Term Investments | 86.64 | 57.81 | - | 123.72 | 125.2 | Upgrade
|
| Cash & Short-Term Investments | 383.33 | 280.32 | 286.33 | 151.72 | 156.54 | Upgrade
|
| Cash Growth | 36.75% | -2.10% | 88.72% | -3.08% | -32.47% | Upgrade
|
| Accounts Receivable | 123.33 | 78.29 | 67.97 | 23.99 | 3.27 | Upgrade
|
| Other Receivables | - | - | - | - | 0.3 | Upgrade
|
| Receivables | 123.33 | 78.29 | 67.97 | 23.99 | 3.57 | Upgrade
|
| Inventory | 24.89 | 22.4 | 22.31 | 5.57 | 1.51 | Upgrade
|
| Prepaid Expenses | 18.14 | 11.78 | 10.94 | 8.95 | 4.97 | Upgrade
|
| Total Current Assets | 549.68 | 392.79 | 387.54 | 190.23 | 166.59 | Upgrade
|
| Property, Plant & Equipment | 10.6 | 9.81 | 1.99 | 2.35 | 2.55 | Upgrade
|
| Long-Term Investments | 8.11 | 12.53 | - | - | 4.98 | Upgrade
|
| Other Intangible Assets | 260.92 | 249.82 | 252.93 | 58.95 | 18.74 | Upgrade
|
| Other Long-Term Assets | 13.5 | 5.81 | 4.17 | 101.38 | 101.79 | Upgrade
|
| Total Assets | 842.81 | 670.75 | 646.62 | 352.91 | 294.65 | Upgrade
|
| Accounts Payable | 9.61 | 14.62 | 7.42 | 8.69 | 9.17 | Upgrade
|
| Accrued Expenses | 105.56 | 70.97 | 54.89 | 34.73 | 24.42 | Upgrade
|
| Current Portion of Leases | 2.14 | 1.71 | 1.1 | 0.93 | 0.71 | Upgrade
|
| Other Current Liabilities | 88.48 | 39.26 | 23.65 | 20.37 | 8.3 | Upgrade
|
| Total Current Liabilities | 205.8 | 126.55 | 87.06 | 64.73 | 42.6 | Upgrade
|
| Long-Term Debt | 309.8 | 308.08 | 306.42 | - | - | Upgrade
|
| Long-Term Leases | 7.52 | 7.97 | 0.62 | 1.26 | 1.9 | Upgrade
|
| Other Long-Term Liabilities | 5.01 | 2.51 | 3.85 | 144.88 | 129.94 | Upgrade
|
| Total Liabilities | 528.12 | 445.11 | 397.95 | 210.87 | 174.44 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 981.88 | 870.19 | 803.26 | 535.07 | 377.4 | Upgrade
|
| Retained Earnings | -667.54 | -644.18 | -556.24 | -392.82 | -257.16 | Upgrade
|
| Comprehensive Income & Other | 0.35 | -0.37 | 1.64 | -0.22 | -0.04 | Upgrade
|
| Total Common Equity | 314.69 | 225.64 | 248.67 | 142.04 | 120.21 | Upgrade
|
| Shareholders' Equity | 314.69 | 225.64 | 248.67 | 142.04 | 120.21 | Upgrade
|
| Total Liabilities & Equity | 842.81 | 670.75 | 646.62 | 352.91 | 294.65 | Upgrade
|
| Total Debt | 319.45 | 317.76 | 308.14 | 2.19 | 2.61 | Upgrade
|
| Net Cash (Debt) | 63.88 | -37.45 | -21.82 | 149.53 | 153.93 | Upgrade
|
| Net Cash Growth | - | - | - | -2.86% | -32.65% | Upgrade
|
| Net Cash Per Share | 1.27 | -0.79 | -0.53 | 4.40 | 5.08 | Upgrade
|
| Filing Date Shares Outstanding | 60.34 | 49.01 | 47 | 37.95 | 31.73 | Upgrade
|
| Total Common Shares Outstanding | 51.9 | 48.34 | 46.72 | 36.96 | 30.58 | Upgrade
|
| Working Capital | 343.89 | 266.24 | 300.48 | 125.5 | 124 | Upgrade
|
| Book Value Per Share | 6.06 | 4.67 | 5.32 | 3.84 | 3.93 | Upgrade
|
| Tangible Book Value | 53.77 | -24.18 | -4.26 | 83.08 | 101.47 | Upgrade
|
| Tangible Book Value Per Share | 1.04 | -0.50 | -0.09 | 2.25 | 3.32 | Upgrade
|
| Machinery | 2.16 | 1.64 | 0.91 | 0.6 | 0.2 | Upgrade
|
| Leasehold Improvements | 0.8 | 0.2 | 1.3 | 1.31 | 1.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.